McKesson's Market Slide: A Cautionary Tale for Investors The recent market slide of McKesson Corporation (MCK) has sent shockwaves through the investment community, with Janus Henderson Global Sustainable Equity Fund highlighting the company as one of its largest detractors in Q2 2026.
The decline raises questions about the factors driving it and what it portends for the broader healthcare industry.
The growing concern over GLP 1 cash pay concerns has led to a widening derating of drug distributors like McKesson, exacerbating existing issues related to insurers and specialty pharmacy exposure.